Back to Journals » Cancer Management and Research » Volume 12

LncRNA HCP5 Stimulates the Proliferation of Non-Small Cell Lung Cancer Cells by Up-Regulating Survivin Through the Down-Regulation of miR-320

Authors Li C, Lei Z, Peng B, Zhu J, Chen L

Received 6 July 2019

Accepted for publication 10 October 2019

Published 14 February 2020 Volume 2020:12 Pages 1129—1134

DOI https://doi.org/10.2147/CMAR.S222221

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Lu-Zhe Sun


Chao Li,1 Zhang Lei,2 Bin Peng,1 Jiang Zhu,1 Li Chen3

1Oncology Department, Second People’s Hospital of Jingmen, Jingmen City, Hubei Province 448000, People’s Republic of China; 2Department of Oncology, The Central Hospital of Wuhan Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei Province 430061, People’s Republic of China; 3Department of Traditional Chinese Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Art and Science, Xiangyang City, Hubei Province 441021, People’s Republic of China

Correspondence: Li Chen
Department of Traditional Chinese Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Art and Science, Jingzhou Street 136#, Xiangyang City, Hubei Province 441021, People’s Republic of China
Tel +86 0710-3522791
Email ojeupkwmky83@163.com

Introduction: We explored the roles of lncRNA HCP5 in non-small cell lung cancer (NSCLC).
Methods: Levels of HCP5 were measured by performing qPCR and data were compared between non-tumor and NSCLC tissue samples by performing a paired t-test. Expression levels of miR-320 and survivin mRNA in NSCLC tissues were also measured by performing qPCR. The effects of HCP5, miR-320 and survivin overexpression on the proliferation of H23 cells were analyzed by cell proliferation assay.
Results: We found that HCP5 was up-regulated in NSCLC and predicted the poor survival of NSCLC patients. HCP5 was negatively correlated with miR-320 but positively correlated with survivin in NSCLC tissues. In NSCLC cells, HCP5 overexpression led to the up-regulated survivin and down-regulated miR-320. Moreover, miR-320 overexpression failed to affect HCP5 but down-regulated survivin. Cell proliferation assay showed that HCP5 and survivin overexpression led to increased, while miR-320 overexpression led to decreased cell proliferation rate. In addition, miR-320 overexpression reduced the effects of HCP5 overexpression.
Conclusion: Therefore, HCP5 may stimulate the proliferation of NSCLC cells by up-regulating survivin through the down-regulation of miR-320.

Keywords: HCP5, non-small cell lung cancer, miR-320, survivin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]